AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
The event, held at Accenture’s New York City office, featured eleven women-led companies addressing critical gaps in women’s health.
NEW YORK, NY, UNITED STATES, June 18, 2025 /EINPresswire.com/ -- Springboard Enterprises, the world-leading accelerator in advancing women-led innovation, is proud to announce the successful presentation of its 2025 Women’s Health Cohort during a live Demo Day held at Accenture’s New York City office.
Eleven companies, each led by a female founder, showcased their innovative solutions spanning reproductive health, oncology, menopause, digital therapeutics, maternal care, and sexual wellness. These companies are addressing long-standing gaps in women’s health - an area that remains significantly underfunded despite its vital importance and scale. Closing this gap is more than a moral imperative; it represents a global economic opportunity valued at over $1 trillion.
The eleven companies selected for the 2025 Women’s Health Accelerator Program presented their work at Accenture’s New York City office to an audience of over 120 investors, healthcare leaders, and industry experts.
“We are incredibly proud to see our 2025 Women’s Health Cohort take the stage and share their vision for a more inclusive and effective healthcare future. Each of these companies represents the kind of bold thinking and targeted innovation that women’s health has lacked for far too long.”
- Miranda Ewald, Director of Programs, Springboard Enterprises
Springboard’s Women’s Health Accelerator Program is a curated experience designed for women-led companies advancing solutions across the health continuum. Throughout the program, participants receive strategic guidance, mentorship from industry experts, and access to Springboard’s powerful network of advisors, partners, and alumnae. The program culminates in a public Showcase and Demo Day, where founders present their progress and engage directly with potential partners, investors, and supporters.
2025 Women’s Health Cohort
·Calla Lily Clinical Care - Dr. Lara Zibners, Co-Founder
Developing the Callavid® platform, a leak-free, dosage-confident vaginal drug delivery system designed to improve administration of therapeutics for conditions like miscarriage prevention, fertility support, and gynecological cancers.
·Couplet Care - Stacie McEntyre, CEO
Redesigned hospital bassinet engineered for safe and ergonomic rooming-in, enhancing mother-infant bonding and supporting postpartum recovery, especially for mothers recovering from cesarean sections.
·Curio Digital Therapeutics - Dr. Shailja Dixit, CEO
Offers MamaLift Plus™, the first FDA-cleared prescription digital therapeutic for postpartum depression, utilizing neurobehavioral interventions like CBT to provide symptom relief.
·Dionysus Digital Health - Dr. Andrea Cubitt, Co-Founder & CEO
Combines epigenetic home testing with an AI-driven app to forecast and manage mental health conditions, including postpartum depression, enabling personalized wellness strategies.
·Emagine Solutions Technology - Courtney Williams, Co-Founder & CEO
Provides "The Journey" platform, integrating remote patient monitoring, a pregnancy tracking app, and handheld ultrasound technology to improve maternal health outcomes.
·Feminai - Dr. Karny Ilan, Co-Founder & CEO
Developing AI-powered solutions to detect early signs of neurodegenerative risks linked to hormonal transitions, aiming to support women's cognitive health during menopause.
·LUWI - Lisa Kinsella, Founder & CEO
Introduces a non-hormonal, over-the-counter contraceptive and STI prevention product designed for women, offering an alternative to traditional condoms with a focus on comfort and empowerment.
·Nalu Bio - Caitlyn Krebs, Co-Founder & CEO
Utilizes synthetic cannabinoids combined with specific vitamins, developed through predictive AI modeling, to create precision therapies targeting women's health challenges like stress and sleep disorders.
·Oya Femtech Apparel - Mitchella Gilbert, Founder & CEO
Designs high-performance, breathable apparel informed by vaginal microbiome research and real-time data, aiming to support women's health through innovative clothing solutions.
·SimpliFed - Andrea Ippolito, Founder & CEO
Offers an insurance-covered virtual platform providing infant feeding support, empowering families with evidence-based care and guidance during the postpartum period.
·Vella Bioscience - Carolyn Wheeler, CEO, Chairman & Co-Founder
Creates clinically-backed sexual wellness therapeutics formulated to enhance female sexual function, addressing issues related to desire and arousal.
The 2025 cohort also benefited from the guidance of the Springboard Women’s Health Council - a cross-sector group of experienced leaders providing strategic input, insights, and connections. Together, the cohort and council are advancing a shared mission: to close the gender gap in healthcare innovation, investment, and outcomes.
To learn more about the cohort and connect with participating companies, click here.
About Springboard Enterprises
Our mission is to accelerate the growth of women-led entrepreneurial companies through access to essential resources and a global community of experts. We are a leading network of industry experts, investors, and innovators dedicated to building companies at scale led by women who are transforming industries in technology, life sciences and healthcare. Since 2000, over 930+ Springboard portfolio companies seeking investment and human capital for product development and expansion have created over $76B in value. With 225 exits to strategic acquirers, 28 IPOs, and 10 Unicorns, Springboard Entrepreneurs are transforming industries. www.sb.co
Mary Keslo
Springboard Enterprises
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
